Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Filters
Jennifer Jordan, Ph.D., M.S., FSCMR
Associate Professor and ABET Coordinator, Department of Biomedical EngineeringB.S., NC State - Biomedical Engineering | Ph.D., VT-WFU School of Biomedical Engineering and Sciences - Biomedical Engineering | M.S., Wake Forest - Clinical and Population Translational Sciences
Dr. Jordan's research involves translational cardiovascular imaging in cardio-oncology, sarcoidosis, and heart failure.
Tzahi Cohen-Karni
Professor, Biomedical Engineering and Materials Science & EngineeringCarnegie Mellon University
Unique interfaces between biology and nanoscience and nanotechnology
Stephanie Willerth
Associate Professor and Canada Research Chair in Biomedical EngineeringUniversity of Victoria
Biomedical engineering leader advancing stem cell therapies with biomaterial scaffolds that improve cell survival and drive regeneration.
Melanie Gainey
STEM LibrarianCarnegie Mellon University
Melanie Gainey is a trained neuroscientist and spent over 10 years studying the plasticity of neural circuits in sensory cortex.
Juergen Hahn
Professor & Department Head, Biomedical EngineeringRensselaer Polytechnic Institute
Specializes in systems biology and process modeling and analysis with a focus on Autism diagnosis and treatment
Roxanne Mykitiuk
Associate Professor, Osgoode Hall Law SchoolYork University
Roxanne Mykitiuk investigates the legal, ethical and social implications of assisted reproductive and genetic technologies.
Bahram Javidi, Ph.D.
Board of Trustees Distinguished ProfessorUniversity of Connecticut
A professor of electrical and computer engineering, Javidi also leads the Multidimensional Optical Sensing and Imaging Systems (MOSIS) Lab.
James Dahlman
Assistant Professor, Biomedical EngineeringGeorgia Tech - COE
James Dahlman uses molecular biology to rationally design the genetic drugs he delivers.
Jatinder Lamba
Professor | Associate DeanUniversity of Florida
Jatinder Lamba focuses on genomic/epigenomic markers predictive of therapeutic outcome in cancer patients.
Bruce Hecht
CEO and CTOVG2PLAY
Bruce Hecht is an expert at advancing architectural and design methodologies in hardware, software, and systems.